share_log

歌禮製藥-B：翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Feb 21 04:51
Summary by Moomoo AI
歌禮製藥有限公司於2024年2月21日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，該公司在2023年12月19日至2024年2月21日期間，進行了多次股份購回活動，但並未註銷這些股份。最新一次購回發生在2024年2月21日，當日購回800,000股，每股價格介於1.84港元至1.89港元之間，總計花費約1,498,040港元。自普通決議案通過以來，公司在香港聯交所購回的股份總數達到69,291,000股，佔當時已發行股份的6.3737%。該公司確認，所有購回活動均按照香港聯交所的規定進行，並且已獲得董事會的正式授權批准。
歌禮製藥有限公司於2024年2月21日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，該公司在2023年12月19日至2024年2月21日期間，進行了多次股份購回活動，但並未註銷這些股份。最新一次購回發生在2024年2月21日，當日購回800,000股，每股價格介於1.84港元至1.89港元之間，總計花費約1,498,040港元。自普通決議案通過以來，公司在香港聯交所購回的股份總數達到69,291,000股，佔當時已發行股份的6.3737%。該公司確認，所有購回活動均按照香港聯交所的規定進行，並且已獲得董事會的正式授權批准。
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 21 FEBRUARY 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. According to the report, the company conducted several share repurchases between December 19, 2023 and February 21, 2024, but did not write them off. The most recent repurchase took place on 21 February 2024 and repurchased 800,000 shares at a price of between HK$1.84 and HK$1.89 per share for a total cost of approximately HK$1,498,040. Since the adoption of the Ordinary Resolution, the total number of shares repurchased by the company on the Hong Kong Stock Exchange has reached 69,291,000 shares, representing 6.3737% of the shares issued at that time. The Company confirms that all repurchases are conducted in accordance with the provisions of the HKEx and have been formally authorized by the Board of Directors.
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 21 FEBRUARY 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. According to the report, the company conducted several share repurchases between December 19, 2023 and February 21, 2024, but did not write them off. The most recent repurchase took place on 21 February 2024 and repurchased 800,000 shares at a price of between HK$1.84 and HK$1.89 per share for a total cost of approximately HK$1,498,040. Since the adoption of the Ordinary Resolution, the total number of shares repurchased by the company on the Hong Kong Stock Exchange has reached 69,291,000 shares, representing 6.3737% of the shares issued at that time. The Company confirms that all repurchases are conducted in accordance with the provisions of the HKEx and have been formally authorized by the Board of Directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more